Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
November 24, 1999
The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives
D G Smith, A D Gribble, D Haigh, et al.
Genes & Development
|
May 7, 2016
Diverging roles for Lrp4 and Wnt signaling in neuromuscular synapse development during evolution
Leonor Remédio, Katherine D Gribble, Jennifer K Lee, et al.
The Biochemical Journal
|
August 7, 1998
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076
N J Pearce, J W Yates, T A Berkhout, et al.
Frontiers in Public Health
|
October 27, 2023
Breastfeeding and infant care as 'sexed' care work: reconsideration of the three Rs to enable women's rights, economic empowerment, nutrition and health
Karleen D Gribble, Julie P Smith, Tine Gammeltoft, et al.
Arzneimittel-Forschung
|
June 3, 1998
Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs
B J van Vlijmen, N J Pearce, M Bergö, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 24, 2002
SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties
Ian T Forbes, Sara Douglas, Andrew D Gribble, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 20, 2003
Identification of a novel series of selective 5-HT7 receptor antagonists
Ian T Forbes, David G Cooper, Emma K Dodds, et al.
Journal of Medicinal Chemistry
|
August 30, 1996
ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme
A D Gribble, R E Dolle, A Shaw, et al.
Journal of Medicinal Chemistry
|
September 5, 2003
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach
Theo A Berkhout, Frank E Blaney, Angela M Bridges, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo
A D Gribble, R J Ife, A Shaw, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Bioorganic & Medicinal Chemistry Letters
|
November 24, 1999
The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives
D G Smith, A D Gribble, D Haigh, et al.
Genes & Development
|
May 7, 2016
Diverging roles for Lrp4 and Wnt signaling in neuromuscular synapse development during evolution
Leonor Remédio, Katherine D Gribble, Jennifer K Lee, et al.
The Biochemical Journal
|
August 7, 1998
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076
N J Pearce, J W Yates, T A Berkhout, et al.
Frontiers in Public Health
|
October 27, 2023
Breastfeeding and infant care as 'sexed' care work: reconsideration of the three Rs to enable women's rights, economic empowerment, nutrition and health
Karleen D Gribble, Julie P Smith, Tine Gammeltoft, et al.
Arzneimittel-Forschung
|
June 3, 1998
Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs
B J van Vlijmen, N J Pearce, M Bergö, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 24, 2002
SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties
Ian T Forbes, Sara Douglas, Andrew D Gribble, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 20, 2003
Identification of a novel series of selective 5-HT7 receptor antagonists
Ian T Forbes, David G Cooper, Emma K Dodds, et al.
Journal of Medicinal Chemistry
|
August 30, 1996
ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme
A D Gribble, R E Dolle, A Shaw, et al.
Journal of Medicinal Chemistry
|
September 5, 2003
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach
Theo A Berkhout, Frank E Blaney, Angela M Bridges, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo
A D Gribble, R J Ife, A Shaw, et al.
Page
of 7